curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Solid Tumor (Phase I); RAS Mutation; CEACAM5 Interventions: Drug: Intravenous AN4035; Drug: Intravenous AN4035 followed by intravenous EGFR Inhibitor. Sponsors: Adlai Nortye Biopharma Co., Ltd. Not yet recruiting Conditions: Solid Tumor (Phase I); RAS...

Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Substance Use; Children; Cultural Factors Interventions: Behavioral: Returning to the Land – Biodiverse Outdoor Setting; Behavioral: Control Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institute on Drug Abuse (NIDA) Not yet...

Evaluation of Biomechanical Forced During the Practice of Endoscopic Retrograde Cholangiopancreatography

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: ERCP; Biomechanic; Musculoskeletal Disorders Interventions: Device: CAPTIV system Sponsors: Centre Hospitalier Universitaire, Amiens; Central Hospital, Nancy, France; University Hospital, Caen; Clinique de l’Europe, Amiens; Hôpital Privé...

Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury.

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury Interventions: Other: Transcutaneous spinal electrical stimulation (TSES) Sponsors: University of Manitoba Recruiting Conditions: Spinal Cord Injuries (SCI); Spinal Cord Injury; Spinal Injury...

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

by palligoelme@gmail.com | Jul 9, 2026 | Clinical Trials

​ Conditions: Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma; Becotatug Vedotin; Pucotenlimab Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Pucotenlimab Sponsors: West China Second University Hospital Not yet recruiting Conditions: Gastric...
« Older Entries
Next Entries »

Recent Posts

  • Implementing IVM for Fertility Treatment in Clinical Practice
  • Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
  • Onlay vs. Sublay Mesh Hernioplasty for Primary Ventral Hernia
  • Dexmedetomidine Nasal Spray and Postoperative Sore Throat After Bronchoscopy
  • Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitation Service: A Qualitative Study of Healthcare Professionals’ Experiences and Use of a Comfort Care Booklet

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®